244 related articles for article (PubMed ID: 15577944)
21. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
[TBL] [Abstract][Full Text] [Related]
22. Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
Grossman SR; Deato ME; Brignone C; Chan HM; Kung AL; Tagami H; Nakatani Y; Livingston DM
Science; 2003 Apr; 300(5617):342-4. PubMed ID: 12690203
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung.
Xue Q; Sano T; Kashiwabara K; Saito M; Oyama T; Nakajima T
Pathol Int; 2002 Feb; 52(2):103-9. PubMed ID: 11940214
[TBL] [Abstract][Full Text] [Related]
24. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
[TBL] [Abstract][Full Text] [Related]
25. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.
Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX
Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463
[TBL] [Abstract][Full Text] [Related]
26. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
27. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
28. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
[TBL] [Abstract][Full Text] [Related]
29. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
Honda R; Yasuda H
Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
[TBL] [Abstract][Full Text] [Related]
30. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
32. MDM2 negatively regulates the human telomerase RNA gene promoter.
Zhao J; Bilsland A; Jackson K; Keith WN
BMC Cancer; 2005 Jan; 5():6. PubMed ID: 15656906
[TBL] [Abstract][Full Text] [Related]
33. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.
Xirodimas DP; Saville MK; Bourdon JC; Hay RT; Lane DP
Cell; 2004 Jul; 118(1):83-97. PubMed ID: 15242646
[TBL] [Abstract][Full Text] [Related]
34. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
Zhang Y; Xiong Y; Yarbrough WG
Cell; 1998 Mar; 92(6):725-34. PubMed ID: 9529249
[TBL] [Abstract][Full Text] [Related]
35. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
[TBL] [Abstract][Full Text] [Related]
36. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
[TBL] [Abstract][Full Text] [Related]
37. Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
Singh RK; Iyappan S; Scheffner M
J Biol Chem; 2007 Apr; 282(15):10901-7. PubMed ID: 17301054
[TBL] [Abstract][Full Text] [Related]
38. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
[TBL] [Abstract][Full Text] [Related]
39. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
Vega FM; Sevilla A; Lazo PA
Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
[TBL] [Abstract][Full Text] [Related]
40. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells.
Katsuda K; Kataoka M; Uno F; Murakami T; Kondo T; Roth JA; Tanaka N; Fujiwara T
Oncogene; 2002 Mar; 21(13):2108-13. PubMed ID: 11960384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
